G01N 2333/505
Erythropoietin [epo]
Official title: Erythropoietin [EPO]
G01N2333/505 (Erythropoietin [epo]) appears on 10 US grants and 16 published applications in this corpus.
Search patents in G01N- Granted patents
- 10
- Published applications
- 16
- Assignees
- 16
- Inventors
- 50
- Latest grant
- 1 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 3 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 2 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers1 Aug 2023US 11,714,093 B2UniversitäT Rostock
- Signal biomarkers12 Jun 2018US 9,994,631 B2Upstream Medical Technologies Limited
- Hypoxia Inducible Factor (HIF) Activity Reporter Cell Line12 Jun 2018US 9,995,730 B2Universiti Putra Malaysia
- Epo knockout GFP anemic mouse10 Nov 2015US 9,180,207 B2Tohoku Techno Arch Co., Ltd.
- Signal biomarkers11 Aug 2015US 9,103,840 B2Otago Innovation Limited
- Method for prediction of response to cardiovascular regeneration4 Jun 2020US 2020/0174020 A1UniversitäT Rostock Zentrale UniversitäTsverwaltung Referat 1.1 Recht
- Signal biomarkers4 Apr 2019US 2019/0100576 A1Upstream Medical Technologies Limited
- Obstructive sleep apnea (osa) biomarker panel7 Jun 2018US 2018/0156820 A1Beckman Coulter, Inc.
- Protein formulations28 Jan 2016US 2016/0025749 A1
- Signal biomarkers10 Dec 2015US 2015/0353632 A1Otago Innovation Limited
Most cited
By later US patents